Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review.

Radiother OncolJul 10, 2026 (epub)

Niki Nourmohammadi, Camellia Kashani, Talia Oughourlian et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined the definitions and assessments of local control (LC) following stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). Out of 155 studies, 113 were included, revealing significant variability in LC terminology and criteria. Notably, 39% of studies defined LC as 'local control', while 32% used 'local failure'.

Key findings

  • 39% of studies defined local control as 'local control', 32% as 'local failure'.
  • 68% of studies assessed progression within the same lobe for local control evaluations.
  • 95.7% of articles published after 2021 limited local control evaluations to primary tumor control.

Why it matters

Inconsistent definitions of local control can hinder effective comparisons of treatment outcomes and complicate clinical decision-making. Standardizing these definitions is essential for improving the assessment of SBRT efficacy in early-stage NSCLC.

Source

Published in Radiother Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Radiology (Diagnostic)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.